Monounsaturated fatty acids generated via stearoyl CoA desaturase-1 are endogenous inhibitors of fatty acid amide hydrolase

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 47, 2013, Pages 18832-18837

  Liu, Jie ^a   Cinar, Resat ^a   Xiong, Keming ^a   Godlewski, Grzegorz ^a   Jourdan, Tony ^a   Lin, Yuhong ^a   Ntambi, James M ^b   Kunos, George ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

A 939572; ACYL COENZYME A DESATURASE 1; ANANDAMIDE; CANNABINOID 1 RECEPTOR; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; FATTY ACID AMIDASE; GLUCOSE; INSULIN; MONOUNSATURATED FATTY ACID; OLEIC ACID; OXYGENASE INHIBITOR; PALMITOLEIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; GLUCOSE INTOLERANCE; IN VITRO STUDY; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; LIVER CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AMIDOHYDROLASES; ANALYSIS OF VARIANCE; ANIMALS; ARACHIDONIC ACIDS; BENZAMIDES; CARBAMATES; ENDOCANNABINOIDS; FATTY ACIDS, MONOUNSATURATED; FEEDBACK, PHYSIOLOGICAL; INSULIN RESISTANCE; LIVER; MALE; MICE; MICE, INBRED C57BL; OBESITY; POLYUNSATURATED ALKAMIDES; RECEPTOR, CANNABINOID, CB1; STEAROYL-COA DESATURASE;

EID: 84888091333     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1309469110     Document Type: Article

References (50)

1. Pacher P, Bátkai S, Kunos G (2006) The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 58(3-389-462
2. Liu J, et al. (2008) Multiple pathways involved in the biosynthesis of anandamide. Neuropharmacology 54(1-1-7
3. Cravatt BF, et al. (1996) Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384(6604-83-87
4. Karlsson M, Contreras JA, Hellman U, Tornqvist H, Holm C (1997) cDNA cloning, tissue distribution, and identification of the catalytic triad of monoglyceride lipase. Evolutionary relationship to esterases, lysophospholipases, and haloperoxidases. J Biol Chem 272(43-27218-27223
5. Dinh TP, et al. (2002) Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci USA 99(16-10819-10824
6. Bracey MH, Hanson MA, Masuda KR, Stevens RC, Cravatt BF (2002) Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling. Science 298(5599-1793-1796
7. McKinney MK, Cravatt BF (2005) Structure and function of fatty acid amide hydrolase. Annu Rev Biochem 74:411-432
8. Osei-Hyiaman D, et al. (2005) Cocaine- and amphetamine-related transcript is involved in the orexigenic effect of endogenous anandamide. Neuroendocrinology 81(4-273-282
9. Ligresti A, Petrosino S, Di Marzo V (2009) From endocannabinoid profiling to 'endocannabinoid therapeutics'. Curr Opin Chem Biol 13(3-321-331
10. Cota D, et al. (2003) The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest 112(3-423-431
11. Osei-Hyiaman D, et al. (2005) Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J Clin Invest 115(5-1298-1305
12. Tam J, et al. (2012) Peripheral cannabinoid-1 receptor inverse agonism reduces obesity by reversing leptin resistance. Cell Metab 16(2-167-179
13. Kathuria S, et al. (2003) Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 9(1-76-81
14. Petrosino S, Di Marzo V (2010) FAAH and MAGL inhibitors: therapeutic opportunities from regulating endocannabinoid levels. Curr Opin Investig Drugs 11(1-51-62
15. Godlewski G, et al. (2010) Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effects. Chem Biol 17(11-1256-1266
16. Touriño C, Oveisi F, Lockney J, Piomelli D, Maldonado R (2010) FAAH deficiency promotes energy storage and enhances the motivation for food. Int J Obes (Lond) 34(3-557-568
17. Ntambi JM, et al. (2002) Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc Natl Acad Sci USA 99(17-11482-11486
18. Cohen P, et al. (2002) Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss. Science 297(5579-240-243
19. Friedman JM, Halaas JL (1998) Leptin and the regulation of body weight in mammals. Nature 395(6704-763-770
20. Ntambi JM (1992) Dietary regulation of stearoyl-CoA desaturase 1 gene expression in mouse liver. J Biol Chem 267(15-10925-10930
21. Jiang G, et al. (2005) Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase-1. J Clin Invest 115(4-1030-1038
22. Gutiérrez-Juárez R, et al. (2006) Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistance. J Clin Invest 116(6-1686-1695
23. Ravinet Trillou C, Delgorge C, Menet C, Arnone M, Soubrié P (2004) CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity. Int J Obes Relat Metab Disord 28(4-640-648
24. Katayama K, et al. (1997) Distribution of anandamide amidohydrolase in rat tissues with special reference to small intestine. Biochim Biophys Acta 1347(2-3-212-218
25. Schmid PC, Zuzarte-Augustin ML, Schmid HH (1985) Properties of rat liver N-acylethanolamine amidohydrolase. J Biol Chem 260(26-14145-14149
26. Mukhopadhyay B, et al. (2011) Hyperactivation of anandamide synthesis and regulation of cell-cycle progression via cannabinoid type 1 (CB1) receptors in the regenerating liver. Proc Natl Acad Sci USA 108(15-6323-6328
27. Liu J, et al. (2012) Hepatic cannabinoid receptor-1 mediates diet-induced insulin resistance via inhibition of insulin signaling and clearance in mice. Gastroenterology 142(5-1218-1228, e1
28. Osei-Hyiaman D, et al. (2008) Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice. J Clin Invest 118(9-3160-3169
29. Sampath H, Miyazaki M, Dobrzyn A, Ntambi JM (2007) Stearoyl-CoA desaturase-1 mediates the pro-lipogenic effects of dietary saturated fat. J Biol Chem 282(4- 2483-2493
30. Due A, et al. (2008) Comparison of the effects on insulin resistance and glucose tolerance of 6-mo high-monounsaturated-fat, low-fat, and control diets. Am J Clin Nutr 87(4-855-862
31. Marks KA, Kitson AP, Stark KD (2013) Hepatic and plasma sex differences in saturated and monounsaturated fatty acids are associated with differences in expression of elongase 6, but not stearoyl-CoA desaturase in Sprague-Dawley rats. Genes Nutr 8(3- 317-327
32. Fu S, et al. (2011) Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity. Nature 473(7348-528-531
33. Man WC, Miyazaki M, Chu K, Ntambi J (2006) Colocalization of SCD1 and DGAT2: Implying preference for endogenous monounsaturated fatty acids in triglyceride synthesis. J Lipid Res 47(9-1928-1939
34. Man WC, Miyazaki M, Chu K, Ntambi JM (2006) Membrane topology of mouse stearoyl-CoA desaturase 1. J Biol Chem 281(2-1251-1260
35. Mileni M, et al. (2010) Crystal structure of fatty acid amide hydrolase bound to the carbamate inhibitor URB597: Discovery of a deacylating water molecule and insight into enzyme inactivation. J Mol Biol 400(4-743-754
36. Kim YJ, Hernandez ML, Balla T (2013) Inositol lipid regulation of lipid transfer in specialized membrane domains. Trends Cell Biol 23(6-270-278
37. Grapov D, Adams SH, Pedersen TL, Garvey WT, Newman JW (2012) Type 2 diabetes associated changes in the plasma non-esterified fatty acids, oxylipins and endocannabinoids. PLoS ONE 7(11-e48852
38. Jeong WI, et al. (2008) Paracrine activation of hepatic CB1 receptors by stellate cellderived endocannabinoids mediates alcoholic fatty liver. Cell Metab 7(3-227-235
39. Després JP, Golay A, Sjöström L; Rimonabant in Obesity-Lipids Study Group (2005) Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N Engl J Med 353(20-2121-2134
40. Hollister LE, Reaven GM (1974) Delta-9-tetrahydrocannabinol and glucose tolerance. Clin Pharmacol Ther 16(2-297-302
41. Rodondi N, Pletcher MJ, Liu K, Hulley SB, Sidney S; Coronary Artery Risk Development in Young Adults (CARDIA) Study (2006) Marijuana use, diet, body mass index, and cardiovascular risk factors (from the CARDIA study). Am J Cardiol 98(4-478-484
42. Muniyappa R, et al. (2013) Metabolic effects of chronic cannabis smoking. Diabetes Care 36(8-2415-2422
43. Hirvonen J, et al. (2012) Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers. Mol Psychiatry 17(6- 642-649
44. Zimmer A, Zimmer AM, Hohmann AG, Herkenham M, Bonner TI (1999) Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc Natl Acad Sci USA 96(10-5780-5785
45. Miyazaki M, Man WC, Ntambi JM (2001) Targeted disruption of stearoyl-CoA desaturase1 gene in mice causes atrophy of sebaceous and meibomian glands and depletion of wax esters in the eyelid. J Nutr 131(9-2260-2268
46. Liu J, et al. (2003) Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3-kinase/NF-kappaB independently of plateletactivating factor. J Biol Chem 278(45-45034-45039
47. Kotronen A, et al. (2009) Hepatic stearoyl-CoA desaturase (SCD)-1 activity and diacylglycerol but not ceramide concentrations are increased in the nonalcoholic human fatty liver. Diabetes 58(1-203-208
48. Masood A, Stark KD, Salem N, Jr. (2005) A simplified and efficient method for the analysis of fatty acid methyl esters suitable for large clinical studies. J Lipid Res 46(10- 2299-2305
49. Wang L, Liu J, Harvey-White J, Zimmer A, Kunos G (2003) Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice. Proc Natl Acad Sci USA 100(3-1393-1398
50. Morrison WR, Smith LM (1964) Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanol. J Lipid Res 5:600-608.